Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study (original) (raw)
Gallipoli, Paolo, Shepherd, Pat, Irvine, David, Drummond, Mark and Holyoake, Tessa(2011) Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study.British Journal of Haematology, 155(1), pp. 128-130. (doi: 10.1111/j.1365-2141.2011.08653.x)
Full text not currently available from Enlighten.
Publisher's URL: http://dx.doi.org/10.1111/j.1365-2141.2011.08653.x
Abstract
No abstract available.
| Item Type: | Articles (Letter) |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Drummond, Dr Mark and Irvine, Dr David and Holyoake, Professor Tessa and Gallipoli, Dr Paolo |
| Authors: | Gallipoli, P., Shepherd, P., Irvine, D., Drummond, M., and Holyoake, T. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
| Journal Name: | British Journal of Haematology |
| Journal Abbr.: | Brit. J. Haematol. |
| Publisher: | Blackwell |
| ISSN: | 0007-1048 |
| ISSN (Online): | 1365-2141 |
| Published Online: | 22 April 2011 |
| Related URLs: | PubMed |
University Staff: Request a correction | Enlighten Editors: Update this record